Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric tolvaptan randomized withdrawal study in hospitalized hyponatremia
2013-002005-59Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tolvaptan in hyponatraemia (2 arms), sponsored by Otsuka Pharmaceutical Development & Commercialization. Primary endpoint: Primary efficacy endpoint. Started Nov 2014; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on 2013-002005-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002005-59.